GeneFormatics Inc. and Arakis Limited have announced a collaborative agreement for the joint discovery of Performance Enhanced Medicines (PEMs). PEMs are novel pharmaceutical products created using advances in biology to identify applications of established drugs in new indications. Additional clinical and patient benefit is provided using a diverse range of pharmaceutical technologies primarily drug delivery Read more about GeneFormatics Inc. And Arakis Agree Drug Discovery Collaboration[…]